» Authors » Antien L Mooyaart

Antien L Mooyaart

Explore the profile of Antien L Mooyaart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 917
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kerkour T, Meijers R, Hollestein L, Jansen A, Haanappel A, Atmodimedjo P, et al.
Melanoma Res . 2025 Feb; PMID: 39912776
Melanoma metastasis poses a significant challenge due to its aggressive nature and increasing incidence. Confirming the clonal relationship between the primary melanoma and its metastasis is essential to developing reliable...
2.
Zhou C, Mooyaart A, Kerkour T, Louwman M, Wakkee M, Li Y, et al.
Eur J Epidemiol . 2025 Jan; 40(1):27-42. PMID: 39786688
Early-stage cutaneous melanoma patients generally have a favorable prognosis, yet a significant proportion of metastatic melanoma cases arise from this group, highlighting the need for improved risk stratification using novel...
3.
van Dal M, Martens-de Kemp S, Mooyaart A, Voogt W, Wakkee M, Damman J
J Cutan Pathol . 2024 Sep; 51(12):980-986. PMID: 39276021
Background: One of the hereditary syndromes associated with multiple early-onset basal cell carcinomas (BCCs) is basal cell nevus syndrome (BCNS), of which a minority is caused by germline SUFU mutations....
4.
Laeijendecker A, El Sharouni M, Stathonikos N, Spoto C, van de Wiel B, Eijken E, et al.
J Clin Pathol . 2024 Feb; 77(6):372-377. PMID: 38378246
Identification of sentinel node (SN) metastases can set the adjuvant systemic therapy indication for stage III melanoma patients. For stage IIIA patients, a 1.0 mm threshold for the largest SN...
5.
Stassen R, Mulder E, Mooyaart A, Francken A, Hage J, Aarts M, et al.
Eur J Surg Oncol . 2023 Oct; 49(12):107249. PMID: 37907016
Sentinel lymph node biopsy (SLNB) is recommended for patients with >pT1b cutaneous melanoma, and should be considered and discussed with patients diagnosed with pT1b cutaneous melanoma for the purpose of...
6.
Eggermont C, Hollestein L, Hollatz A, Louwman M, Mooyaart A, Nijsten T, et al.
J Am Acad Dermatol . 2023 Oct; 90(3):530-536. PMID: 37871807
Background: There is lack of nationwide data on the cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas (cSCCs) among patients with a first cSCC. Objective: To investigate the...
7.
Rentroia-Pacheco B, Tokez S, Bramer E, Venables Z, van de Werken H, Bellomo D, et al.
EClinicalMedicine . 2023 Sep; 63:102150. PMID: 37662519
Background: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer, affecting more than 2 million people worldwide yearly and metastasising in 2-5% of patients. However, current clinical staging systems...
8.
Morrel B, Pasmans S, Mooyaart A, van der Avoort I
Skin Health Dis . 2023 Aug; 3(4):e233. PMID: 37538320
No abstract available.
9.
Giang J, Mooyaart A, Martens-de Kemp S, Jaspars L, Wakkee M, Eijken E, et al.
J Cutan Pathol . 2023 Jan; 50(7):674-680. PMID: 36607280
We present two cases of plaque-type trichoblastoma with atypical foci. A rare variant of trichoblastoma is the plaque variant, which is characterized by poor circumscription and locally infiltrative growth pattern....
10.
Vermarien-Wang J, Doeleman T, van Doorn R, Mooyaart A, Blokx W, Schrader A
J Am Acad Dermatol . 2022 Nov; 88(3):602-608. PMID: 36403750
Background: Melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) are descriptive and provisional terms for melanocytic tumors with ambiguous histopathological features that...